Jaguar Animal Health, Inc. (NASDAQ:JAGX)’s share price was down NaN during trading on Thursday . The stock traded as low as $0.17 and last traded at $0.00. Approximately 819,726 shares were traded during trading, an increase of Infinity from the average daily volume of 0 shares.
Several equities analysts recently commented on JAGX shares. Rodman & Renshaw started coverage on shares of Jaguar Animal Health in a research note on Tuesday, July 11th. They set a “buy” rating and a $2.00 target price for the company. HC Wainwright set a $2.00 target price on shares of Jaguar Animal Health and gave the company a “buy” rating in a research note on Tuesday, July 11th.
About Jaguar Animal Health
Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
What are top analysts saying about Jaguar Animal Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Jaguar Animal Health Inc. and related companies.